{"id":"shen26-capsule","safety":{"commonSideEffects":[{"rate":"null","effect":"Pain, redness, or swelling at the injection site"},{"rate":"null","effect":"Fatigue"},{"rate":"null","effect":"Headache"}]},"_chembl":{"chemblId":"CHEMBL206253","moleculeType":"Small molecule","molecularWeight":"578.60"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"It works by inducing an immune response against the virus, which helps to prevent infection and disease. The exact mechanism of action is not fully understood, but it is thought to involve the activation of immune cells and the production of antibodies that can neutralize the virus.","oneSentence":"SHEN26 capsule is a vaccine that targets the SARS-CoV-2 spike protein.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:52:59.058Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention of COVID-19"}]},"trialDetails":[{"nctId":"NCT05908071","phase":"PHASE3","title":"Study Evaluating SHEN26 Capsule in Patients With Mild to Moderate COVID-19","status":"UNKNOWN","sponsor":"Shenzhen Kexing Pharmaceutical Co., Ltd.","startDate":"2023-05-13","conditions":"COVID-19","enrollment":1200},{"nctId":"NCT05676073","phase":"PHASE2","title":"Study of SHEN26 Capsule in Patients With Mild to Moderate COVID-19","status":"COMPLETED","sponsor":"Shenzhen Kexing Pharmaceutical Co., Ltd.","startDate":"2022-12-08","conditions":"COVID-19","enrollment":91},{"nctId":"NCT05504746","phase":"PHASE1","title":"A Phase I Study of SHEN26 Capsule in Healthy Participants","status":"COMPLETED","sponsor":"Shenzhen Kexing Pharmaceutical Co., Ltd.","startDate":"2022-08-08","conditions":"Healthy Participants","enrollment":86}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"SHEN26 capsule","genericName":"SHEN26 capsule","companyName":"Shenzhen Kexing Pharmaceutical Co., Ltd.","companyId":"shenzhen-kexing-pharmaceutical-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"SHEN26 capsule is a vaccine that targets the SARS-CoV-2 spike protein. Used for Prevention of COVID-19.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}